Varex Imaging Corporation
$11.97
▼
-1.13%
2026-04-21 10:10:00
www.vareximaging.com
NMS: VREX
Explore Varex Imaging Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$501.54 M
Current Price
$11.97
52W High / Low
$14.56 / $6.76
Stock P/E
—
Book Value
$11.38
Dividend Yield
—
ROCE
7.18%
ROE
-12.9%
Face Value
—
EPS
$-1.64
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
2,400
Beta
1
Debt / Equity
81.76
Current Ratio
3.89
Quick Ratio
1.83
Forward P/E
10.61
Price / Sales
0.55
Enterprise Value
$758.04 M
EV / EBITDA
7.8
EV / Revenue
0.89
Rating
Buy
Target Price
$18.4
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 2. | Lifeward Ltd. | $7.52 | — | $11.49 M | — | -155.52% | -1.46% | $18.6 / $4.14 | $5.52 |
| 3. | InMode Ltd. | $14.57 | 9.84 | $923.14 M | — | 12.27% | 13.53% | $16.74 / $12.72 | $10.78 |
| 4. | Profound Medical Corp. | $7.15 | — | $331 M | — | -57.78% | -67.11% | $12.4 / $5.23 | $1.83 |
| 5. | Cytek Biosciences, Inc. | $4.57 | — | $592.62 M | — | -10.52% | -18.05% | $6.18 / $2.37 | $2.66 |
| 6. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 7. | Enovis Corporation | $26.27 | — | $1.52 B | — | -0.58% | -58.27% | $37.85 / $21 | $26.05 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 209.6 M | 228.9 M | 203 M | 212.9 M | 199.8 M |
| Operating Profit | 15.4 M | 19.6 M | 13.2 M | 22.1 M | 11.2 M |
| Net Profit | 2.3 M | 12.2 M | -89.1 M | 6.9 M | -0.3 M |
| EPS in Rs | 0.05 | 0.29 | -2.13 | 0.16 | -0.01 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 844.6 M | 811 M | 893.4 M | 859.4 M |
| Operating Profit | 66.1 M | 32.1 M | 77.1 M | 88.2 M |
| Net Profit | -70.3 M | -48.8 M | 47.4 M | 30.3 M |
| EPS in Rs | -1.68 | -1.16 | 1.13 | 0.72 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.11 B | 1.21 B | 1.25 B | 1.18 B |
| Total Liabilities | 620.8 M | 670.4 M | 668.6 M | 637.7 M |
| Equity | 472.6 M | 529.1 M | 567.7 M | 533.4 M |
| Current Assets | 641.8 M | 649.9 M | 658.3 M | 609.9 M |
| Current Liabilities | 187.2 M | 195.9 M | 162.8 M | 173.1 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 41.7 M | 47.3 M | 108.4 M | 16.9 M |
| Investing CF | 10.3 M | -27.5 M | -44.9 M | -48.4 M |
| Financing CF | -75.9 M | -3.3 M | -0.2 M | -23.8 M |
| Free CF | 18.8 M | 20.4 M | 87.7 M | -4.4 M |
| Capex | -22.9 M | -26.9 M | -20.7 M | -21.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 4.14% | -9.22% | 3.96% | — |
| Earnings Growth % | -44.06% | -202.95% | 56.44% | — |
| Profit Margin % | -8.32% | -6.02% | 5.31% | 3.53% |
| Operating Margin % | 7.83% | 3.96% | 8.63% | 10.26% |
| Gross Margin % | 34.39% | 31.68% | 32.49% | 32.99% |
| EBITDA Margin % | 0.08% | 7.76% | 10.21% | 13.32% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.